Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07944859

Impact of Advanced Parkinson Therapies on Clinical Status: Deep Brain Stimulation and Foslevodopa/Foscarbidopa

Sponsor: Medical University of Warsaw

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn how treatment with selected advanced therapies for Parkinson's disease affect disease motor symptoms, cognition, body weight, body composition and inflammatory biomarkers in people with advanced Parkinson's disease. The main questions it aims to answer are: * How do clinical symptoms, cognitive function, body composition and blood biomarkers change during the first 12 months after starting the treatment? * Are there differences in outcomes between participants treated with DBS and those treated with foslevodopa/foscarbidopa infusion? Participants will: * Undergo deep brain stimulation (DBS) or start continuous subcutaneous foslevodopa/foscarbidopa infusion as part of their routine clinical care. * Attend study visits over 12 months and complete assessments of motor and non-motor symptoms, cognition, gait and balance. * Provide blood samples and undergo magnetic resonance imaging (MRI) and body composition measurements.

Official title: The Impact of Selected Advanced Therapies on the Clinical Status of Patients With Parkinson's Disease.

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

92

Start Date

2025-03-19

Completion Date

2029-03-28

Last Updated

2026-11-18

Healthy Volunteers

No

Locations (1)

Department of Neurology at Mazowiecki Bródnowski Hospital

Warsaw, Masovian Voivodeship, Poland